Elevated AST and ALT levels, characteristic of impaired liver function in T2DM mice, were also reduced following combination treatment: AST decreased to 160 ± 9.6 U/L (Figure 4C) and ALT to 50 ± 6.4 U/L (Figure 4D), with significant differences between groups (** p < 0.01). The gene discussed is GPT; the disease is type 2 diabetes mellitus.